Related Experiment Video
Updated: Sep 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Optoregulated mRNA Delivery Controls Pleiotropic Immune Signaling for Tumor-Targeted Therapy
Pengwen Chen1, Guanghao Hu1, Yuki Nakashima1
1Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
A novel Light-Induced Transfection System (LITS) enables precise control over messenger RNA (mRNA) therapeutics. This system allows for targeted protein expression in tumors, enhancing antitumor activity while minimizing toxicity for safer therapies.
Area of Science:
- Biotechnology
- Therapeutics
- Molecular Biology
Background:
- Spatiotemporal control of protein expression is crucial for mRNA therapeutics, especially in tumor-targeted treatments.
- Current methods face challenges in achieving precise delivery and localized activation of mRNA therapies.
Purpose of the Study:
- To introduce a Light-Induced Transfection System (LITS) for spatiotemporal control of mRNA translation.
- To demonstrate LITS's capability for localized protein expression and modulation of therapeutic effects in targeted tissues.
Main Methods:
- Developed LITS using photosensitizing polymers for systemic mRNA delivery.
- Activated mRNA translation via light-triggered endosomal escape in irradiated tissues.
- Utilized interleukin-2 (IL-2) as a model therapeutic to assess LITS efficacy.
Main Results:
- LITS enabled localized protein expression in irradiated tumors, triggering proinflammatory cytokine levels.
- Nonirradiated healthy tissues showed tolerogenic IL-2 levels, reducing systemic toxicity.
- LITS synergized IL-2 efficacy, driving immunogenic cell death and eradicating lung metastasis in a breast cancer model.
Conclusions:
- LITS provides a programmable platform for on-demand, targeted mRNA therapies.
- The system offers precise spatial control over protein expression, enhancing therapeutic efficacy.
- LITS demonstrates potential for safe and effective cancer treatment by modulating IL-2's effects.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi

